Antares Pharma Inc (ATRS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, and adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharmas injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs its drug delivery systems to advance drug compounds and drug delivery methods. It also advances various product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc (ATRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antares Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antares Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Lumara Health Enters into Licensing Agreement with Antares Pharma 11
Equity Offering 12
Antares Pharma to Raise up to USD30 Million in Public Offering of Shares 12
Antares Pharma Raises USD46 Million in Public Offering of Shares 13
Antares Pharma Completes Partial Exercise Of Underwriters Over-Allotment Option For Public Offering Of Shares For US$57 Million 15
Antares Pharma Inc - Key Competitors 17
Antares Pharma Inc - Key Employees 18
Antares Pharma Inc - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results 20
Nov 07, 2017: Antares Pharma Reports Third Quarter 2017 Operating and Financial Results 22
Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results 24
May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results 26
Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results 28
Product Approvals 30
Feb 27, 2017: Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot Testosterone 30
Clinical Trials 31
May 16, 2017: Antares Pharma Announces Poster Presentation at the American Urological Association Annual Meeting 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List Of Tables

List of Tables
Antares Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antares Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antares Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Antares Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lumara Health Enters into Licensing Agreement with Antares Pharma 11
Antares Pharma to Raise up to USD30 Million in Public Offering of Shares 12
Antares Pharma Raises USD46 Million in Public Offering of Shares 13
Antares Pharma Completes Partial Exercise Of Underwriters Over-Allotment Option For Public Offering Of Shares For US$57 Million 15
Antares Pharma Inc, Key Competitors 17
Antares Pharma Inc, Key Employees 18
Antares Pharma Inc, Other Locations 19
Antares Pharma Inc, Subsidiaries 19

List Of Figures

List of Figures
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antares Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9

Antares Pharma Inc (ATRS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel

USD 250 View Report

Antares Pharma Inc (ATRS) - Product Pipeline Analysis, 2018 Update

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel

USD 750 View Report

Avisa Pharma Inc - Product Pipeline Analysis, 2019 Update

Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available